Human Immunodeficiency Virus (HIV) Diagnosis Market Forecast To Reach $7.4 Billion By 2030: Key Trends Explained

Human Immunodeficiency Virus (HIV) Diagnosis Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Human Immunodeficiency Virus (HIV) Diagnosis Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The human immunodeficiency virus (hiv) diagnosis market size has undergone rapid expansion in recent years. It is forecasted to grow from $4.67 billion in 2025 to $5.19 billion in 2026, recording a compound annual growth rate (CAGR) of 11.0%. The historical growth in this sector is attributable to factors such as the global prevalence of hiv infections, government-led hiv screening programs, the increased availability of rapid diagnostic kits, the expansion of diagnostic laboratory infrastructure, and growing public health awareness initiatives.

The human immunodeficiency virus (hiv) diagnosis market is set to experience robust growth in the coming years. It is anticipated to expand to $7.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is fueled by an escalating demand for early hiv detection, the increasing uptake of self-test kits, the advancement of point-of-care diagnostic technologies, a heightened focus on hiv prevention and monitoring, and rising investments in infectious disease diagnostics. Significant trends foreseen in this period include the growing adoption of rapid and point-of-care hiv testing, an increased emphasis on early and routine hiv screening, a burgeoning demand for self-testing and home-based diagnostics, the expansion of integrated hiv testing and counseling services, and a greater concentration on data-driven hiv surveillance and reporting.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=38830773&type=smp&name=Human%20Immunodeficiency%20Virus%20%28HIV%29%20Diagnosis%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Human Immunodeficiency Virus (HIV) Diagnosis Market Development Factors: What’s Supporting Demand?

The growth of the HIV diagnosis market is projected to be driven by increasing blood donations. Blood donation involves the voluntary collection of blood through phlebotomy, a procedure where a needle is inserted into a vein. The surge in blood donations is attributed to advancements in medical technology, robust community engagement, and improved methods for donor recruitment and retention. As more individuals contribute blood, a larger array of samples becomes available for HIV screening. This enhanced availability of blood samples enables more extensive testing for HIV antibodies or antigens, thus improving the accuracy and trustworthiness of HIV diagnosis. For illustration, NHS Blood and Transplant, a government agency in the UK, reported an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, the rising rate of blood donation is a key factor propelling the expansion of the HIV diagnosis market.

Human Immunodeficiency Virus (HIV) Diagnosis Market Segment Analysis And Revenue Potential

The human immunodeficiency virus (hiv) diagnosis market covered in this report is segmented –

1) By Product: Consumables, Instruments, Software, Services

2) By Mode: Self-Test, Lab-Based

3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

Subsegments:

1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment

2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments

3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools

4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing

Human Immunodeficiency Virus (HIV) Diagnosis Market Transformation Trends: What Innovations Are Driving Change?

Leading companies in the human immunodeficiency virus (HIV) diagnosis market are concentrating on developing long-lasting, highly effective prevention and treatment methods, expanding accessibility through robust reimbursement programs, and advancing innovative clinical approaches to enhance adherence and decrease new HIV infections. For example, in June 2025, Gilead Sciences, a US-based healthcare company, secured FDA approval for Yeztugo (lenacapavir), the first and only twice-yearly injectable PrEP option, representing a significant leap forward in HIV prevention. Supported by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug exhibited exceptional efficacy, with =99.9% of participants remaining HIV-negative. This long-acting injection aims to mitigate challenges such as adherence difficulties, stigma, and limited awareness that currently restrict PrEP usage. Yeztugo’s approval presents a promising resource for reducing new HIV infections across various populations. Gilead is also rolling out extensive access initiatives, including collaborations with insurance providers, co-pay assistance for eligible patients, and free access for uninsured individuals via support programs.

Human Immunodeficiency Virus (HIV) Diagnosis Market Key Players Shaping Industry Direction

Major companies operating in the human immunodeficiency virus (hiv) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Molecular Diagnostics, Atila BioSystems Inc.

View The Full Human Immunodeficiency Virus (HIV) Diagnosis Market Report:

https://thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Human Immunodeficiency Virus (HIV) Diagnosis Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the HIV diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (hiv) diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model